Galectin Therapeutics Inc (GALT)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
393,314,000
EV to revenue ratio (TTM)
EV to ebitda
-4.039
Financial Performance
Revenue (TTM)
0
Gross profit (TTM)
0
EBITDA
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-64.20%
Return on equity (TTM)
-3,728.00%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-0.43
Diluted EPS (TTM)
-0.43
Book value
-2.1
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
4.543
PEG ratio
0
Price to sales ratio (TTM)
Price to book ratio (TTM)
207.7
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
1
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.386